Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease.
Foster CB, Lehrnbecher T, Mol F, Steinberg SM, Venzon DJ, Walsh TJ, Noack D, Rae J, Winkelstein JA, Curnutte JT, et al. J Clin Invest. 1998 Dec 15; 102(12):2146-55.